(Q38267957)

English

MicroRNAs in Schizophrenia: Implications for Synaptic Plasticity and Dopamine-Glutamate Interaction at the Postsynaptic Density. New Avenues for Antipsychotic Treatment Under a Theranostic Perspective.

scientific article

In more languages

default for all languages

No label defined

No description defined

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25394379%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

1 reference

Europe PubMed Central

MicroRNAs in Schizophrenia: Implications for Synaptic Plasticity and Dopamine-Glutamate Interaction at the Postsynaptic Density. New Avenues for Antipsychotic Treatment Under a Theranostic Perspective (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25394379%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

0 references

0 references

1 reference

based on heuristic

inferred from title

synaptic plasticity

1 reference

based on heuristic

inferred from title

Andrea de Bartolomeis

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25394379%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

author name string

Felice Iasevoli

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25394379%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Carmine Tomasetti

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25394379%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Elisabetta F Buonaguro

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25394379%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

publication date

14 November 2014

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25394379%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Molecular Neurobiology

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25394379%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

52

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25394379%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25394379%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

1771-1790

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25394379%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Schizophrenia as a disorder of molecular pathways

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

Serotonin-glutamate and serotonin-dopamine reciprocal interactions as putative molecular targets for novel antipsychotic treatments: from receptor heterodimers to postsynaptic scaffolding and effector proteins.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

Rethinking schizophrenia in the context of normal neurodevelopment

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

Abnormal cortical growth in schizophrenia targets normative modules of synchronized development

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

Schizophrenia is associated with elevated amphetamine-induced synaptic dopamine concentrations: evidence from a novel positron emission tomography method

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

Glutamate, dopamine, and schizophrenia: from pathophysiology to treatment

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

Striatal D2/D3 receptor occupancy, clinical response and side effects with amisulpride: an iodine-123-iodobenzamide SPET study

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

Treatment-resistant schizophrenia

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

microRNA expression in the prefrontal cortex of individuals with schizophrenia and schizoaffective disorder

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

Gene-microRNA interactions associated with antipsychotic mechanisms and the metabolic side effects of olanzapine.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

Differential regulation of mature and precursor microRNA expression by NMDA and metabotropic glutamate receptor activation during LTP in the adult dentate gyrus in vivo

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

Expression of microRNAs and their precursors in synaptic fractions of adult mouse forebrain

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

miRNA regulons associated with synaptic function

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

Control of translation and mRNA degradation by miRNAs and siRNAs

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

The nuclear RNase III Drosha initiates microRNA processing

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

MicroRNAs: small RNAs with a big role in gene regulation

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

Characterization of DGCR8/Pasha, the essential cofactor for Drosha in primary miRNA processing

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

Distinct roles for Drosophila Dicer-1 and Dicer-2 in the siRNA/miRNA silencing pathways

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

Human Argonaute2 mediates RNA cleavage targeted by miRNAs and siRNAs

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

Mechanisms of post-transcriptional regulation by microRNAs: are the answers in sight?

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

Stress-induced reversal of microRNA repression and mRNA P-body localization in human cells.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

Switching from repression to activation: microRNAs can up-regulate translation

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

Expression profiling of mammalian microRNAs uncovers a subset of brain-expressed microRNAs with possible roles in murine and human neuronal differentiation

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

Transcriptome-wide discovery of microRNA binding sites in human brain.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

miR-124 regulates adult neurogenesis in the subventricular zone stem cell niche

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

MicroRNAs in neuronal communication.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

A functional screen implicates microRNA-138-dependent regulation of the depalmitoylation enzyme APT1 in dendritic spine morphogenesis

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

The microRNA miR-124 antagonizes the anti-neural REST/SCP1 pathway during embryonic CNS development

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

Identification of many microRNAs that copurify with polyribosomes in mammalian neurons

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

Specific microRNAs modulate embryonic stem cell-derived neurogenesis.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

Reciprocal actions of REST and a microRNA promote neuronal identity

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

Dicer loss in striatal neurons produces behavioral and neuroanatomical phenotypes in the absence of neurodegeneration

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

Conditional loss of Dicer disrupts cellular and tissue morphogenesis in the cortex and hippocampus

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

Dicer ablation in oligodendrocytes provokes neuronal impairment in mice

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

MicroRNA loss enhances learning and memory in mice

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

Deletion of astroglial Dicer causes non-cell-autonomous neuronal dysfunction and degeneration

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

Staufen- and FMRP-containing neuronal RNPs are structurally and functionally related to somatic P bodies

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

Dicer and eIF2c are enriched at postsynaptic densities in adult mouse brain and are modified by neuronal activity in a calpain-dependent manner

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

Synapse- and stimulus-specific local translation during long-term neuronal plasticity

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

Noncoding RNAs in the mammalian central nervous system.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

Non-coding RNAs in the nervous system

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

Sequence variants in SLITRK1 are associated with Tourette's syndrome

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

From mRNP trafficking to spine dysmorphogenesis: the roots of fragile X syndrome

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

Fragile X-related protein and VIG associate with the RNA interference machinery

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

Heterogeneous dysregulation of microRNAs across the autism spectrum.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

Feasibility and relevance of examining lymphoblastoid cell lines to study role of microRNAs in autism

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

Regulation of synaptic structure and function by FMRP-associated microRNAs miR-125b and miR-132

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

Scaffolding proteins of the post-synaptic density contribute to synaptic plasticity by regulating receptor localization and distribution: relevance for neuropsychiatric diseases

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

Calcium-dependent networks in dopamine-glutamate interaction: the role of postsynaptic scaffolding proteins.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

Glutamatergic postsynaptic density protein dysfunctions in synaptic plasticity and dendritic spines morphology: relevance to schizophrenia and other behavioral disorders pathophysiology, and implications for novel therapeutic approaches.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

MicroRNA-132 dysregulation in schizophrenia has implications for both neurodevelopment and adult brain function

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

Dysregulation of miRNA 181b in the temporal cortex in schizophrenia.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

High rates of schizophrenia in adults with velo-cardio-facial syndrome.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

Altered brain microRNA biogenesis contributes to phenotypic deficits in a 22q11-deletion mouse model

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

Palmitoylation-dependent neurodevelopmental deficits in a mouse model of 22q11 microdeletion.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

Derepression of a neuronal inhibitor due to miRNA dysregulation in a schizophrenia-related microdeletion

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

Dysregulation of presynaptic calcium and synaptic plasticity in a mouse model of 22q11 deletion syndrome

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

Age-dependent microRNA control of synaptic plasticity in 22q11 deletion syndrome and schizophrenia

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

Upregulation of dicer and microRNA expression in the dorsolateral prefrontal cortex Brodmann area 46 in schizophrenia.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

Altered microRNA expression profiles in postmortem brain samples from individuals with schizophrenia and bipolar disorder

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

Differential expression of exosomal microRNAs in prefrontal cortices of schizophrenia and bipolar disorder patients

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

Expression of NPAS3 in the human cortex and evidence of its posttranscriptional regulation by miR-17 during development, with implications for schizophrenia

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

Strong association of de novo copy number mutations with sporadic schizophrenia

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

A MicroRNA gene is hosted in an intron of a schizophrenia-susceptibility gene.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

Gender-Specific Reduction of Estrogen-Sensitive Small RNA, miR-30b, in Subjects With Schizophrenia

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

MicroRNA in schizophrenia: genetic and expression analysis of miR-130b (22q11)

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

Brain expressed microRNAs implicated in schizophrenia etiology

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

MicroRNAs and target site screening reveals a pre-microRNA-30e variant associated with schizophrenia.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

Evidence for X-chromosomal schizophrenia associated with microRNA alterations

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

Genome-wide association study identifies five new schizophrenia loci

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

MicroRNA miR-137 regulates neuronal maturation by targeting ubiquitin ligase mind bomb-1

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

Analysis of miR-137 expression and rs1625579 in dorsolateral prefrontal cortex

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

Impact of a microRNA MIR137 susceptibility variant on brain function in people at high genetic risk of schizophrenia or bipolar disorder

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

The genome-wide supported microRNA-137 variant predicts phenotypic heterogeneity within schizophrenia

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

Mood congruent psychotic symptoms and specific cognitive deficits in carriers of the novel schizophrenia risk variant at MIR-137.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

Genome-wide supported variant MIR137 and severe negative symptoms predict membership of an impaired cognitive subtype of schizophrenia.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

Evaluation of six SNPs of MicroRNA machinery genes and risk of schizophrenia

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

MicroRNA expression aberration as potential peripheral blood biomarkers for schizophrenia

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

Imprinted DLK1-DIO3 region of 14q32 defines a schizophrenia-associated miRNA signature in peripheral blood mononuclear cells

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

Aberrant expression of serum miRNAs in schizophrenia

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

In vivo microRNA detection and quantitation in cerebrospinal fluid

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

Dopamine Receptor Binding Predicts Clinical and Pharmacological Potencies of Antischizophrenic Drugs

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

Dopamine receptors and the dopamine hypothesis of schizophrenia

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

Single photon emission computerized tomography imaging of amphetamine-induced dopamine release in drug-free schizophrenic subjects

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

Presynaptic dopamine function in striatum of neuroleptic-naive schizophrenic patients.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

Increased dopamine synthesis rate in medial prefrontal cortex and striatum in schizophrenia indicated by L-(beta-11C) DOPA and PET.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

Prefrontal DA Transmission at D1 Receptors and the Pathology of Schizophrenia

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

Inverted-U dopamine D1 receptor actions on prefrontal neurons engaged in working memory

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

From revolution to evolution: the glutamate hypothesis of schizophrenia and its implication for treatment

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

The glutamatergic aspects of schizophrenia molecular pathophysiology: role of the postsynaptic density, and implications for treatment

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

Ketamine-induced exacerbation of psychotic symptoms and cognitive impairment in neuroleptic-free schizophrenics.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

Association of ketamine-induced psychosis with focal activation of the prefrontal cortex in healthy volunteers

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

Comparative and interactive human psychopharmacologic effects of ketamine and amphetamine: implications for glutamatergic and dopaminergic model psychoses and cognitive function

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

Proton magnetic resonance spectroscopy of the substantia nigra in schizophrenia

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

Delayed alternation performance following subchronic phencyclidine administration in rats depends on task parameters.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

Reversal of PCP-induced learning and memory deficits in the Morris' water maze by sertindole and other antipsychotics.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

Chronic infusion of PCP via osmotic mini-pumps: a new rodent model of cognitive deficit in schizophrenia characterized by impaired attentional set-shifting (ID/ED) performance

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

Effect of pretreatment with risperidone on phencyclidine-induced disruptions in object recognition memory and prefrontal cortex parvalbumin immunoreactivity in the rat.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

NMDA receptor hypofunction model of schizophrenia

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

Effects of ketamine and N-methyl-D-aspartate on glutamate and dopamine release in the rat prefrontal cortex: modulation by a group II selective metabotropic glutamate receptor agonist LY379268.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

Clozapine and haloperidol differently suppress the MK-801-increased glutamatergic and serotonergic transmission in the medial prefrontal cortex of the rat.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

Chronic NMDA antagonism impairs working memory, decreases extracellular dopamine, and increases D1 receptor binding in prefrontal cortex of conscious monkeys

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

Regulation of dopamine D1 receptor dynamics within the postsynaptic density of hippocampal glutamate synapses

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

Synergistic interactions of dopamine D1 and glutamate NMDA receptors in rat hippocampus and prefrontal cortex: involvement of ERK1/2 signaling.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

Dopamine D1 activation potentiates striatal NMDA receptors by tyrosine phosphorylation-dependent subunit trafficking

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

The physiology, signaling, and pharmacology of dopamine receptors

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

Interaction of dopamine D1 with NMDA NR1 receptors in rat prefrontal cortex

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

Divergent acute and chronic modulation of glutamatergic postsynaptic density genes expression by the antipsychotics haloperidol and sertindole

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

Imaging brain gene expression profiles by antipsychotics: region-specific action of amisulpride on postsynaptic density transcripts compared to haloperidol

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

Dopamine receptor subtypes contribution to Homer1a induction: insights into antipsychotic molecular action

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

PSD-95 expression controls L-DOPA dyskinesia through dopamine D1 receptor trafficking

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

Calcyon forms a novel ternary complex with dopamine D1 receptor through PSD-95 protein and plays a role in dopamine receptor internalization

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

PSD-95 uncouples dopamine-glutamate interaction in the D1/PSD-95/NMDA receptor complex

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

D-Aspartic acid is a novel endogenous neurotransmitter.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

New insights on the role of free D-aspartate in the mammalian brain

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

Decreased levels of D-aspartate and NMDA in the prefrontal cortex and striatum of patients with schizophrenia.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

D-aspartate prevents corticostriatal long-term depression and attenuates schizophrenia-like symptoms induced by amphetamine and MK-801.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

Exposure to novel environment is characterized by an interaction of D1/NMDA receptors underlined by phosphorylation of the NMDA and AMPA receptor subunits and activation of ERK1/2 signaling, leading to epigenetic changes and gene expression in rat h

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

MicroRNA 142-3p mediates post-transcriptional regulation of D1 dopamine receptor expression

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

Differential allelic expression of dopamine D1 receptor gene (DRD1) is modulated by microRNA miR-504.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

miR-142-3p restricts cAMP production in CD4+CD25- T cells and CD4+CD25+ TREG cells by targeting AC9 mRNA.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

Dopamine facilitates dendritic spine formation by cultured striatal medium spiny neurons through both D1 and D2 dopamine receptors

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

Effects of dopamine and glutamate on synaptic plasticity: a computational modeling approach for drug abuse as comorbidity in mood disorders

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

Interaction between N-methyl-D-aspartic acid receptors and D1 dopamine receptors: an important mechanism for brain plasticity

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

Postsynaptic density scaffolding proteins at excitatory synapse and disorders of synaptic plasticity: implications for human behavior pathologies.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

The postsynaptic architecture of excitatory synapses: a more quantitative view

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

Postsynaptic scaffold proteins at non-synaptic sites. The role of postsynaptic scaffold proteins in motor-protein-receptor complexes

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

PDZ domain proteins of synapses

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

Evolutionary expansion and anatomical specialization of synapse proteome complexity.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

CaMKII: a biochemical bridge linking accumbens dopamine and glutamate systems in cocaine seeking

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

DARPP-32 is a robust integrator of dopamine and glutamate signals

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

Group I metabotropic glutamate receptor-mediated gene expression in striatal neurons

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

Regulation of Akt and Wnt signaling by the group II metabotropic glutamate receptor antagonist LY341495 and agonist LY379268.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

The dopamine D2 receptor regulates Akt and GSK-3 via Dvl-3.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

A novel Ca2+-independent signaling pathway to extracellular signal-regulated protein kinase by coactivation of NMDA receptors and metabotropic glutamate receptor 5 in neurons.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

Regulation of Akt signaling by D2 and D3 dopamine receptors in vivo

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

Altered transcript expression of NMDA receptor-associated postsynaptic proteins in the thalamus of subjects with schizophrenia

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

Abnormalities of the NMDA Receptor and Associated Intracellular Molecules in the Thalamus in Schizophrenia and Bipolar Disorder

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

Primary microRNA precursor transcripts are localized at post-synaptic densities in adult mouse forebrain

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

Glucocorticoid attenuates brain-derived neurotrophic factor-dependent upregulation of glutamate receptors via the suppression of microRNA-132 expression

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

MicroRNA-219 modulates NMDA receptor-mediated neurobehavioral dysfunction

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

MicroRNA-148/152 impair innate response and antigen presentation of TLR-triggered dendritic cells by targeting CaMKIIα.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

Hippocampal demyelination and memory dysfunction are associated with increased levels of the neuronal microRNA miR-124 and reduced AMPA receptors

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

MicroRNA-223 is neuroprotective by targeting glutamate receptors

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

Potential Impact of miR-137 and Its Targets in Schizophrenia

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

An activity-regulated microRNA controls dendritic plasticity by down-regulating p250GAP

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

In vivo regulation of Homer1a expression in the striatum by cocaine

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

Homer splice variants modulation within cortico-subcortical regions by dopamine D2 antagonists, a partial agonist, and an indirect agonist: implication for glutamatergic postsynaptic density in antipsychotics action

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

Cocaine activates Homer1 immediate early gene transcription in the mesocorticolimbic circuit: differential regulation by dopamine and glutamate signaling

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

Dopamine-regulated microRNA MiR-181a controls GluA2 surface expression in hippocampal neurons

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

microRNAs miR-124, let-7d and miR-181a regulate cocaine-induced plasticity

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

In vivo composition of NMDA receptor signaling complexes differs between membrane subdomains and is modulated by PSD-95 and PSD-93

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

Neurotransmitters drive combinatorial multistate postsynaptic density networks.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

Targeting Homer genes using adeno-associated viral vector: lessons learned from behavioural and neurochemical studies.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

Differential expression of Homer 1 gene by acute and chronic administration of antipsychotics and dopamine transporter inhibitors in the rat forebrain

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

Ketamine-related expression of glutamatergic postsynaptic density genes: possible implications in psychosis

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

The postsynaptic density

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

PSD-95 regulates D1 dopamine receptor resensitization, but not receptor-mediated Gs-protein activation

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

Up-regulation of NMDA receptor subunit and post-synaptic density protein expression in the thalamus of elderly patients with schizophrenia

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

Perinatal phencyclidine treatment alters neuregulin 1/erbB4 expression and activation in later life.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

Association of mouse Dlg4 (PSD-95) gene deletion and human DLG4 gene variation with phenotypes relevant to autism spectrum disorders and Williams' syndrome

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

Changes in NMDA receptor subunits and interacting PSD proteins in dorsolateral prefrontal and anterior cingulate cortex indicate abnormal regional expression in schizophrenia

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

Effects of antipsychotic drugs on the expression of synaptic proteins and dendritic outgrowth in hippocampal neuronal cultures

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

Different effects of the NMDA receptor antagonists ketamine, MK-801, and memantine on postsynaptic density transcripts and their topography: role of Homer signaling, and implications for novel antipsychotic and pro-cognitive targets in psychosis

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

Haloperidol induces higher Homer1a expression than risperidone, olanzapine and sulpiride in striatal sub-regions

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

Pattern of acute induction of Homer1a gene is preserved after chronic treatment with first- and second-generation antipsychotics: effect of short-term drug discontinuation and comparison with Homer1a-interacting genes

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

Reversible inhibition of PSD-95 mRNA translation by miR-125a, FMRP phosphorylation, and mGluR signaling

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

MicroRNA regulation of homeostatic synaptic plasticity

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

Coupling of mGluR/Homer and PSD-95 complexes by the Shank family of postsynaptic density proteins

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

Distinct roles for different Homer1 isoforms in behaviors and associated prefrontal cortex function.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

Complex, multimodal behavioral profile of the Homer1 knockout mouse.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

Homer-1 polymorphisms are associated with psychopathology and response to treatment in schizophrenic patients

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

Mutation screening of the Homer gene family and association analysis in schizophrenia

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

The role of Homer 1a in increasing locomotor activity and non-selective attention, and impairing learning and memory abilities.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

Nucleus accumbens Homer proteins regulate behavioral sensitization to cocaine

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

Behavioral sensitization to cocaine is associated with increased glutamate receptor trafficking to the postsynaptic density after extended withdrawal period

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

Protein-protein interactions as therapeutic targets in neuropsychopharmacology

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

Antipsychotic drug actions on gene modulation and signaling mechanisms

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

Regulation of PI3K/Akt signaling by N-desmethylclozapine through activation of δ-opioid receptor

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

Targeting glutamate system for novel antipsychotic approaches: relevance for residual psychotic symptoms and treatment resistant schizophrenia.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

A gene expression and systems pathway analysis of the effects of clozapine compared to haloperidol in the mouse brain implicates susceptibility genes for schizophrenia.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

Alterations to melanocortinergic, GABAergic and cannabinoid neurotransmission associated with olanzapine-induced weight gain

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

Intracellular pathways of antipsychotic combined therapies: implication for psychiatric disorders treatment.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

Pharmacological treatment of schizophrenia: a critical review of the pharmacology and clinical effects of current and future therapeutic agents

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

Identification of developmentally regulated PCP-responsive non-coding RNA, prt6, in the rat thalamus

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

Evidence for selective microRNAs and their effectors as common long-term targets for the actions of mood stabilizers

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

Silencing of microRNAs in vivo with 'antagomirs'

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

LNA-mediated microRNA silencing in non-human primates

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

microRNAs in CNS disorders

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

Silencing of microRNA families by seed-targeting tiny LNAs

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

Regulation of opioid tolerance by let-7 family microRNA targeting the mu opioid receptor

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

Striatal microRNA controls cocaine intake through CREB signalling

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

Multifunctional iron oxide nanoparticles for diagnostics, therapy and macromolecule delivery

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

A brain-targeted rabies virus glycoprotein-disulfide linked PEI nanocarrier for delivery of neurogenic microRNA.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

The road toward microRNA therapeutics

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

Therapeutic Advances in MicroRNA Targeting

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

Polymer nanoparticle-mediated delivery of microRNA inhibition and alternative splicing

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

Solid lipid nanoparticles loaded with anti-microRNA oligonucleotides (AMOs) for suppression of microRNA-21 functions in human lung cancer cells.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

MicroRNAs - a new generation molecular targets for treating cellular diseases

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

MicroRNA-206: a promising theranostic marker.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

MicroRNA expression signatures determine prognosis and survival in glioblastoma multiforme--a systematic overview.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

Can microRNAs improve the management of lung cancer patients? A clinician's perspective

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

Micro-RNAs as potential new molecular biomarkers in oncology: have they reached relevance for the clinical imaging sciences?

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

Lost in translation. New unexplored avenues for neuropsychopharmacology: epigenetics and microRNAs

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

Micro spies from the brain to the periphery: new clues from studies on microRNAs in neuropsychiatric disorders

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

De novo CNV analysis implicates specific abnormalities of postsynaptic signalling complexes in the pathogenesis of schizophrenia.

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

Genetic and functional analysis of the DLG4 gene encoding the post-synaptic density protein 95 in schizophrenia

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

Transcriptional consequences of schizophrenia candidate miR-137 manipulation in human neural progenitor cells

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

Submicroscopic deletions at 22q11.2: Variability of the clinical picture and delineation of a commonly deleted region

1 reference

https://api.crossref.org/works/10.1007%2FS12035-014-8962-8

21 January 2018

Dopamine D1 receptor-dependent trafficking of striatal NMDA glutamate receptors to the postsynaptic membrane.

1 reference

https://pubmed.ncbi.nlm.nih.gov/25394379

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Recent evidence for dopamine abnormalities in schizophrenia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/25394379

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Alpha-noradrenergic receptor modulation of the phencyclidine- and delta9-tetrahydrocannabinol-induced increases in dopamine utilization in rat prefrontal cortex

1 reference

https://pubmed.ncbi.nlm.nih.gov/25394379

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Activation of glutamatergic neurotransmission by ketamine: a novel step in the pathway from NMDA receptor blockade to dopaminergic and cognitive disruptions associated with the prefrontal cortex

1 reference

https://pubmed.ncbi.nlm.nih.gov/25394379

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Phencyclidine increases forebrain monoamine metabolism in rats and monkeys: modulation by the isomers of HA966.

1 reference

https://pubmed.ncbi.nlm.nih.gov/25394379

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Ketamine activates psychosis and alters limbic blood flow in schizophrenia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/25394379

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Schizophrenia is associated with an increase in cortical microRNA biogenesis

1 reference

https://pubmed.ncbi.nlm.nih.gov/25394379

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Investigation of post-transcriptional gene regulatory networks associated with autism spectrum disorders by microRNA expression profiling of lymphoblastoid cell lines

1 reference

https://pubmed.ncbi.nlm.nih.gov/25394379

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Altered gene expression and neuropathology in Alzheimer's disease

1 reference

https://pubmed.ncbi.nlm.nih.gov/25394379

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Increased hippocampal glutamate and volumetric deficits in unmedicated patients with schizophrenia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/25394379

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Prefrontal dopamine D1 receptors and working memory in schizophrenia.

1 reference

https://pubmed.ncbi.nlm.nih.gov/25394379

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

MicroRNA conjugated gold nanoparticles and cell transfection

1 reference

https://pubmed.ncbi.nlm.nih.gov/25394379

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Regional decoupling of N-acetyl-aspartate and glutamate in schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/25394379

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

MicroRNAs -the next generation therapeutic targets in human diseases

1 reference

https://pubmed.ncbi.nlm.nih.gov/25394379

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The role of D1-dopamine receptor in working memory: local injections of dopamine antagonists into the prefrontal cortex of rhesus monkeys performing an oculomotor delayed-response task

1 reference

https://pubmed.ncbi.nlm.nih.gov/25394379

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

MicroRNA expression profiling in the prefrontal cortex of individuals affected with schizophrenia and bipolar disorders

1 reference

https://pubmed.ncbi.nlm.nih.gov/25394379

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Biomarkers in schizophrenia

1 reference

https://pubmed.ncbi.nlm.nih.gov/25394379

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

The Homer family and the signal transduction system at glutamatergic postsynaptic density: potential role in behavior and pharmacotherapy

1 reference

https://pubmed.ncbi.nlm.nih.gov/25394379

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Therapeutic evaluation of microRNAs by molecular imaging

1 reference

https://pubmed.ncbi.nlm.nih.gov/25394379

12 December 2020

based on heuristic

inferred from PubMed ID database lookup

Identifiers

10.1007/S12035-014-8962-8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25394379%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

Dimensions Publication ID

0 references

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25394379%20AND%20SRC:MED&resulttype=core&format=json

22 February 2020

ResearchGate publication ID

0 references

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q38267957&oldid=2201498589"